Method for bAdge-dosi Monitoring of X-ray Exposure Values in Operating Theatre Surgery
NCT ID: NCT06659939
Last Updated: 2025-05-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
240 participants
OBSERVATIONAL
2024-10-01
2025-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
In order to increase the proportion of dosimeters systematically worn in the operating room, we study the impact of the association of the passive dosimeter with the hospital access badge (forming the Badge-Dosi). A first pilot study was carried out at Tours University Hospital showing the effectiveness of this concept. With the present study, we carry out a multicenter study. Our hypothesis is that the Badge-Dosi allows a significant increase of dosimeter use in the operating room, which improves the reliability of the monitoring of personnel.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Reference Dose Levels During Fluoroscopically Guided Procedures in Operating Rooms
NCT03649451
A Prospective Study of Radiation Exposure to Surgeons
NCT00378053
Randomized Comparison of Radiation Exposure to Operators in Coronary Intervention Between Right Radial and Left DRA
NCT05702060
Current Practice of Patients Undergoing C-arm Procedures at the Operating Department
NCT05238129
Randomized Comparison of Radiation Exposure in Coronary Angiography Between Right Conventional and Left Distal Radial Artery Approach
NCT04023838
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
TEST group
The TEST group's participants will be randomized in order to either wear the dosimeter alone (as usual) or the dosimeter associated with the access badge of the hospital "badge-dosi".
The participants are working in the operating room and are exposed to X-rays
No interventions assigned to this group
LIFE group
The LIFE group participants will wear a dosimeter associated with the access badge of the hospital "badge-dosi".
The participants are working in the same hospital as the TEST group, but they are not exposed to any radiation at work.
No interventions assigned to this group
HOME group
The HOME group participants will have a dosimeter alone which will be stored at home. The participants are working in the same hospital as the TEST group.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* People working in the operating room at least 80% of the time (excluding people working less than 80% of the time).
* Have been monitored by a delayed-reading dosimeter for at least 1 year.
* Carry an access card (i.e. be the holder).
LIFE group :
* Person working in the same centre as the people in the TEST group.
* Person not exposed to radiation at their workstation
* Holder of an access card
HOME group :
\- Person working in the same centre as people in the TEST Group and live near the center
Exclusion Criteria
* Person objecting to data processing
* Interns/externs/non-permanent staff likely to change jobs during the study period
* Person who had a nuclear medicine examination within 15 days before the start of the study
* Anyone who had internal vectorised therapy with iodine-131 or Lu-177 within 30 days before the start of the study.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Tours
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University hospital
Orléans, , France
University hospital
Toulouse, , France
University hospital
Tours, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DR240215 - MAVERIC
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.